Infosys Limited has informed the Exchange regarding 'Infosys Announces Strategic Collaboration with Zoetis to Enhance Digital Capabilities'.

Strategic Transactions View source PDF Explain this filing

INFY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.3%Reaction day

₹1584.70

prior close

₹1577.80

announcement price

In-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)+0.4%-0.7% vs market

Computers - Software & Consulting peers, median of 59sector+0.6%-0.9% vs sector

On the reaction day the stock moved 0.7 pts less than Nifty 100 and 0.9 pts less than its Computers - Software & Consulting peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.3+0.4-0.7+0.6-0.9

Next day

+1.8+1.1+0.6+1.8-0.1

+1.9+2.3-0.4+2.5-0.6

+1.7+2.7-1.0+2.5-0.8

+1.2+2.4-1.2+2.1-1.0

+1.2+2.4-1.3+2.5-1.4

+2.0+1.8+0.2+2.0+0.0

15d

+0.2+1.2-1.1+1.9-1.8

-2.0+0.7-2.7+0.6-2.6

-3.2+0.2-3.5-3.3+0.1

-5.7+0.8-6.5-3.1-2.6

UpDownMarket · Nifty 100Sector · Computers - Software & Consulting peers, median of 59Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Infosys has entered a long-term strategic collaboration with Zoetis, the world's leading animal health company and a Fortune 500 firm that reported $9.3 billion in revenue in 2024. The deal focuses on improving Zoetis' IT operations by integrating AI solutions and automation services to boost agility and efficiency. The engagement will support Zoetis' business growth across veterinarians, livestock producers, and pet owners globally. Infosys highlighted this as part of its commitment to delivering AI-driven digital solutions to the Life Sciences sector. No financial terms or deal value were disclosed.

Likely market impact

This adds a marquee Fortune 500 client win for Infosys in the Life Sciences vertical, reinforcing its AI and digital transformation portfolio. Likely to be viewed positively by investors as a sign of strong demand for Infosys' services, though the absence of deal value limits immediate earnings visibility.